Active surveillance protocol in prostate cancer in Portugal

被引:1
|
作者
Gaspar, S. R. da Silva [1 ]
Fernandes, M. [1 ]
Castro, A. [1 ]
Oliveira, T. [1 ]
Dias, J. Santos [1 ]
dos Reis, J. Palma [1 ]
机构
[1] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Dept Urol, Lisbon, Portugal
来源
ACTAS UROLOGICAS ESPANOLAS | 2022年 / 46卷 / 06期
关键词
Active surveillance; Prostate cancer; Watchful waiting; Portugal; MRI; Biopsy; VERSION; 2; MEN; COMPLICATIONS; MANAGEMENT; BIOPSIES;
D O I
10.1016/j.acuro.2021.01.010
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: To examine clinical practice patterns in locally managing patients under an active surveillance protocol among Portuguese urologists. Introduction: Prostate cancer (PCa) is a heterogeneous disease with many prostate adeno-carcinomas being indolent and a low probability of ever causing symptoms or death. Active surveillance (AS) is a form of conservative management aimed to reduce over-treatment for low-risk PCa patients. Over the years, experience with AS has grown considerably and is now standard in some countries, however a universal protocol still does not exist. Methods: Nationwide anonymous e-survey concerning habits and practices on AS among Portu-guese urologists, that consisted of 12 questions and was sent electronically to all 368 current members of the Portuguese Urological Association. Results: 56 urologists were surveyed (15.21% answer rate), evenly distributed geographically and allocated according to years of experience as well as number of PCa patients managed monthly. The vast majority of respondents recommends AS to their patients, particularly ISUP grade 1 patients, whose PSA serum level is bellow 20ng/mL. Observance of AS programs by patients was not in question but concerns exist over psychological morbidity while harboring disease. Majority believed that international guidelines surveillance protocols were adequate and sufficient, but there are some constraints concerning availability of periodic MRIs and re -biopsy needs. Conclusions: AS seems to be sustained in urologist clinical practice, although patients still lag to adhere and choose for active treatment. AS may not be an easy choice for patients and clinicians due to uncertainty of disease progression, risk of loss to follow-up and repeated biopsies but is also a cause for anxiety, depression, uncertainty and a perception of danger. (c) 2021 AEU. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:329 / 339
页数:11
相关论文
共 50 条
  • [1] Active surveillance in prostate cancer: the French protocol
    Mottet, Nicolas
    Irani, Jacques
    PROGRES EN UROLOGIE, 2008, 18 (04): : F12 - F16
  • [2] ACTIVE SURVEILLANCE FOR LOCALIZED PROSTATE CANCER-A PROSPECTIVE PROTOCOL
    Davis, John W.
    Troncoso, Patricia
    Ward, John F.
    Pettaway, Curtis A.
    Pisters, Louis L.
    Kuban, Deborah
    Brown, Victoria
    Logothetis, Christopher
    Kim, Jeri
    JOURNAL OF UROLOGY, 2009, 181 (04): : 177 - 177
  • [3] Staging saturation biopsy in patients with prostate cancer on active surveillance protocol
    Abouassaly, Robert
    Lane, Brian R.
    Jones, J. Stephen
    UROLOGY, 2008, 71 (04) : 573 - 577
  • [4] Active surveillance of prostate cancer
    Hammerer, Peter
    Manka, Lukas
    ONKOLOGE, 2020, 26 (11): : 1069 - 1078
  • [5] Active surveillance for prostate cancer
    Dariane, C.
    PROGRES EN UROLOGIE, 2015, 25 (14): : 884 - 887
  • [6] Active Surveillance of Prostate Cancer
    Choyke, Peter L.
    Loeb, Stacy
    ONCOLOGY-NEW YORK, 2017, 31 (01): : 67 - 70
  • [7] Active surveillance for prostate cancer
    Romero-Otero, Javier
    Garcia-Gomez, Borja
    Duarte-Ojeda, Jose M.
    Rodriguez-Antolin, Alfredo
    Vilaseca, Antoni
    Carlsson, Sigrid V.
    Touijer, Karim A.
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (03) : 211 - 218
  • [8] Active surveillance in prostate cancer
    Erne, E.
    Kaufmann, S.
    Nikolaou, K.
    Stenzl, A.
    Bedke, J.
    UROLOGE, 2019, 58 (05): : 511 - 517
  • [9] Active surveillance of prostate cancer
    Ploussard, G.
    Hennequin, C.
    Rozet, F.
    CANCER RADIOTHERAPIE, 2017, 21 (6-7): : 437 - 441
  • [10] Active Surveillance for Prostate Cancer
    Thompson, Ian M.
    Klotz, Laurence
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (21): : 2411 - 2412